StanleyDruck13F
🛡️ Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients 🛡️ $NTRA (Natera Inc) a global leader in cell-free DNA and genetic testing, today announced that its Prospera Lung test has met coverage requirements from the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostics Services (MolDX) Program for single lung transplant (SLT) recipients. This coverage applies to SLT patients in the surveillance setting. SLT patients make up ~20% of all U.S. lung transplants 1 . These patients are at an increased risk for acute rejection and also for complications from invasive procedures like biopsies due to common factors including advanced age, frailty, comorbidities, and functional dependency on a single lung. This creates an increased need for non-invasive monitoring solutions, like Prospera Lung. 📖 Read more: www.natera.com/company/news/natera-announces-medicare-coverage-for-prospera-in-single-lung-transplant-recipients
Like CommentShare
1 Mentioned
1 reply
null
.